Search Results - "Theijse, Rutger T"

Comment on: Pancreatectomy With Islet-Autotransplantation As Alternative for Pancreatoduodenectomy in Patients With a High-Risk for Postoperative Pancreatic Fistula: The Jury Is Still Out by Stoop, Thomas F, Ghorbani, Poya, Theijse, Rutger T, van Veldhuisen, Charlotte L, DeVries, J Hans, Groot Koerkamp, Bas, van Santvoort, Hjalmar C, Molenaar, I Quintus, Busch, Olivier R, Del Chiaro, Marco, Besselink, Marc G

Get full text

Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer by Stoop, Thomas F., Theijse, Rutger T., Seelen, Leonard W. F., Groot Koerkamp, Bas, van Eijck, Casper H. J., Wolfgang, Christopher L., van Tienhoven, Geertjan, van Santvoort, Hjalmar C., Molenaar, I. Quintus, Wilmink, Johanna W., Del Chiaro, Marco, Katz, Matthew H. G., Hackert, Thilo, Besselink, Marc G.

“…Surgical resection combined with systemic chemotherapy is the cornerstone of treatment for patients with localized pancreatic cancer. Upfront surgery is…”
Get full text

Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study by Doppenberg, Deesje, Stoop, Thomas F., van Dieren, Susan, Katz, Matthew H. G., Janssen, Quisette P., Nasar, Naaz, Prakash, Laura R., Theijse, Rutger T., Tzeng, Ching-Wei D., Wei, Alice C., Zureikat, Amer H., Groot Koerkamp, Bas, Besselink, Marc G.

“…Introduction About 25% of patients with localized pancreatic adenocarcinoma have non-elevated serum carbohydrate antigen (CA) 19-9 levels at baseline,…”
Get full text

Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study by Theijse, Rutger T, Stoop, Thomas F, Janssen, Quisette P, Prakash, Laura R, Katz, Matthew H G, Doppenberg, Deesje, Tzeng, Ching-Wei D, Wei, Alice C, Zureikat, Amer H, Groot Koerkamp, Bas, Besselink, Marc G

“…Abstract Background Surgery in selected patients with locally advanced pancreatic cancer after induction chemotherapy may have drawbacks related to surgical…”
Get full text

Systematic review and Meta-analysis of the Role of total Pancreatectomy as an Alternative to Pancreatoduodenectomy in Patients at High Risk for Postoperative Pancreatic Fistula: is it a Justifiable Indication? by Stoop, Thomas F., Bergquist, Erik, Theijse, Rutger T., Hempel, Sebastian, van Dieren, Susan, Sparrelid, Ernesto, Distler, Marius, Hackert, Thilo, Besselink, Marc G., Del Chiaro, Marco, Ghorbani, Poya

“…Examine the potential benefit of total pancreatectomy (TP) as alternative to pancreatoduodenectomy (PD) in patients at high-risk for postoperative pancreatic…”
Get full text

Surgical outcome of a double versus a single pancreatoduodenectomy per operating day by Theijse, Rutger T., Stoop, Thomas F., Geerdink, Niek J., Daams, Freek, Zonderhuis, Babs M., Erdmann, Joris I., Swijnenburg, Rutger Jan, Kazemier, Geert, Busch, Olivier R., Besselink, Marc G.

“…For logistical reasons, some high-volume centers have developed surgical programs wherein 1 surgical team performs 2 pancreatoduodenectomies on a single day…”
Get full text

ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment—A TAPS Consortium Study by Doppenberg, Deesje, Stoop, Thomas F., van Dieren, Susan, Katz, Matthew H. G., Janssen, Quisette P., Nasar, Naaz, Prakash, Laura R., Theijse, Rutger T., Tzeng, Ching-Wei D., Wei, Alice C., Zureikat, Amer H., Groot Koerkamp, Bas, Besselink, Marc G.

Get full text

ASO Author Reflections: The Value of Serum CEA for Prognostication at Staging and Response Evaluation in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 by Stoop, Thomas F., Doppenberg, Deesje, Katz, Matthew H. G., Tzeng, Ching-Wei D., Wei, Alice C., Zureikat, Amer H., Groot Koerkamp, Bas, Besselink, Marc G.

Get full text

Surgery for Locally Advanced Pancreatic Cancer Following Induction Chemotherapy: A Single-Center Experience by Theijse, Rutger T., Stoop, Thomas F., Leenart, Philip D., Lutchman, Kishan R. D., Erdmann, Joris I., Daams, Freek, Zonderhuis, Babs M., Festen, Sebastiaan, Swijnenburg, Rutger-Jan, van Gulik, Thomas M., Schoorlemmer, Annuska, Sterk, André L. A., van Dieren, Susan, Fariña, Arantza, Voermans, Rogier P., Wilmink, Johanna W., Kazemier, Geert, Busch, Olivier R., Besselink, Marc G.

“…Background The use of surgery in patients with locally advanced pancreatic cancer (LAPC) following induction chemotherapy is increasing. However, most series…”
Get full text

Nationwide Outcome after Pancreatoduodenectomy in Patients at very High Risk (ISGPS-D) for Postoperative Pancreatic Fistula by Theijse, Rutger T, Stoop, Thomas F, Hendriks, Tessa E, Suurmeijer, J Annelie, Smits, F Jasmijn, Bonsing, Bert A, Lips, Daan J, Manusama, Eric, van der Harst, Erwin, Patijn, Gijs A, Wijsman, Jan H, Meerdink, Mark, den Dulk, Marcel, van Dam, Ronald, Stommel, Martijn W J, van Laarhoven, Kees, de Wilde, Roeland F, Festen, Sebastiaan, Draaisma, Werner A, Bosscha, Koop, van Eijck, Casper H J, Busch, Olivier R, Molenaar, I Quintus, Groot Koerkamp, Bas, van Santvoort, Hjalmar C, Besselink, Marc G

“…To assess nationwide surgical outcome after pancreatoduodenectomy (PD) in patients at very high risk for postoperative pancreatic fistula (POPF), categorized…”
Get full text

Nationwide Use and Outcome of Surgery for Locally Advanced Pancreatic Cancer Following Induction Chemotherapy by Stoop, Thomas F., Seelen, Leonard W. F., van ’t Land, Freek R., Lutchman, Kishan R. D., van Dieren, Susan, Lips, Daan J., van der Harst, Erwin, Kazemier, Geert, Patijn, Gijs A., de Hingh, Ignace H., Wijsman, Jan H., Erdmann, Joris I., Festen, Sebastiaan, Groot Koerkamp, Bas, Mieog, J. Sven D., den Dulk, Marcel, Stommel, Martijn W. J., Busch, Olivier R., de Wilde, Roeland F., de Meijer, Vincent E., te Riele, Wouter, Molenaar, I. Quintus, van Eijck, Casper H. J., van Santvoort, Hjalmar C., Besselink, Marc G.

“…Background Several international high-volume centers have reported good outcomes after resection of locally advanced pancreatic cancer (LAPC) following…”
Get full text

ASO Author Reflections: Nationwide Experience on Locally Advanced Pancreatic Cancer Surgery After Induction Chemotherapy in the Netherlands: A Stepping Stone for the PREOPANC-4 Trial by Stoop, Thomas F., Seelen, Leonard W. F., van ‘t Land, Freek R., van Eijck, Casper H. J., van Santvoort, Hjalmar C., Besselink, Marc G.

Get full text

ASO Visual Abstract: Nationwide Use and Outcome of Surgery for Locally Advanced Pancreatic Cancer Following Induction Chemotherapy by Stoop, Thomas F., Seelen, Leonard W. F., van’t Land, Freek R., Lutchman, Kishan R. D., van Dieren, Susan, Lips, Daan J., van der Harst, Erwin, Kazemier, Geert, Patijn, Gijs A., de Hingh, Ignace H., Wijsman, Jan H., Erdmann, Joris I., Festen, Sebastiaan, Groot Koerkamp, Bas, Mieog, J. Sven D., Dulk, Marcel den, Stommel, Martijn W. J., Busch, Olivier R., de Wilde, Roeland F., de Meijer, Vincent E., Riele, Wouter te, Molenaar, I. Quintus, van Eijck, Casper H. J., van Santvoort, Hjalmar C., Besselink, Marc G.

Get full text

Systematic Review and Meta-analysis of the Role of Total Pancreatectomy as an Alternative to Pancreatoduodenectomy in Patients at High Risk for Postoperative Pancreatic Fistula by Stoop, TF, Bergquist, E, Theijse, RT, Hempel, S, van, Dieren S, Sparrelid, E, Distler, M, Hackert, T, Besselink, MG, Del, Chiaro M

Get full text

Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study by Dekker, Esther N, van Dam, Jacob L, Janssen, Quisette P, Besselink, Marc G, DeSilva, Annissa, Doppenberg, Deesje, van Eijck, Casper H J, Nasar, Naaz, O'Reilly, Eileen M, Paniccia, Alessandro, Prakash, Laura R, Tzeng, Ching-Wei D, Verkolf, Eva M M, Wei, Alice C, Zureikat, Amer H, Katz, Matthew H G, Groot Koerkamp, Bas

“…Previous studies suggest that besides anatomy (A: resectable, borderline resectable [BR], or locally advanced [LA]) also biologic (B: carbohydrate antigen 19-9…”
Get full text

Metformin boosts antitumor immunity and improves prognosis in upfront resected pancreatic cancer: an observational study by van Eijck, Casper W F, Vadgama, Disha, van Eijck, Casper H J, Wilmink, Johanna W

“…Beyond demographic and immune factors, metabolic considerations, particularly metformin's recognized impact in oncology, warrant exploration in treating…”
Get full text